Tinnitus Management
For persistent, bothersome tinnitus, recommend cognitive-behavioral therapy (CBT) as the primary evidence-based intervention, hearing aids for those with hearing loss, and avoid routine use of medications, supplements, or dietary interventions. 1
Initial Evaluation
Perform a targeted history and physical examination focusing on:
- Laterality: Unilateral tinnitus requires prompt audiologic evaluation and possible imaging 1
- Quality: Pulsatile tinnitus warrants imaging to exclude vascular or structural pathology 1
- Duration: Distinguish recent onset (<6 months) from persistent (≥6 months) 1
- Associated hearing loss: Most tinnitus occurs with sensorineural hearing loss 1
- Psychiatric comorbidity: Screen for anxiety, depression, and suicidal ideation - this is critical as suicide has been reported in tinnitus patients with coexisting psychiatric illness 1, 2
Diagnostic Testing
Obtain comprehensive audiologic examination for all patients with:
- Unilateral tinnitus
- Persistent tinnitus (≥6 months)
- Associated hearing difficulties 1
Imaging is NOT routinely indicated unless specific red flags are present:
- Unilateral/asymmetric hearing loss
- Pulsatile tinnitus
- Focal neurological abnormalities 1
Treatment Algorithm
Step 1: Education and Counseling
All patients with persistent, bothersome tinnitus should receive education about natural history and management strategies 1. This is foundational and should not be skipped.
Step 2: Address Hearing Loss
If hearing loss is present: Recommend hearing aid evaluation 1. Hearing aids can improve quality of life even with mild hearing loss or unilateral sensorineural hearing loss associated with tinnitus. The 2026 updated guideline 2 also recommends cochlear implant evaluation when patients meet audiologic criteria.
Step 3: Cognitive-Behavioral Therapy
CBT should be recommended for persistent, bothersome tinnitus 1, 2. This is the most valuable evidence-based intervention with RCT support showing preponderance of benefit over harm. The 2026 guideline 2 reinforces this as a strong recommendation.
Step 4: Sound Therapy (Optional)
May recommend sound enrichment/sound therapy as an adjunctive option 1, 2, though evidence is less robust than for CBT.
What NOT to Do
Do NOT routinely prescribe 1:
- Antidepressants
- Anticonvulsants
- Anxiolytics
- Intratympanic medications
These medications lack efficacy evidence, carry significant side effects, and some (particularly antidepressants) may paradoxically worsen tinnitus. The exception would be treating a primary psychiatric disorder that happens to coexist with tinnitus.
Do NOT recommend 1:
- Ginkgo biloba
- Melatonin
- Zinc
- Other dietary supplements
The 2026 guideline 2 and 2025 VA/DOD guideline 3 reinforce these recommendations against supplements.
- Repetitive transcranial magnetic stimulation (rTMS) - insufficient evidence and not recommended for routine treatment
Common Pitfalls
Over-imaging: Resist ordering MRI/CT for every tinnitus patient. Reserve imaging for red flags only.
Prescribing medications reflexively: Despite patient expectations, medications are not effective for primary tinnitus treatment and expose patients to unnecessary risks.
Missing psychiatric comorbidity: Always assess for depression, anxiety, and suicidal ideation - these require prompt intervention and can be life-threatening 1, 2.
Underutilizing hearing aids: Even patients with mild hearing loss may benefit from amplification for tinnitus relief 1.
Not distinguishing bothersome from non-bothersome tinnitus: This distinction is critical for prioritizing interventions 1, 2.
Outcome Monitoring
Document and assess outcomes of interventions systematically 2. This allows for adjustment of management strategies based on patient response.
The evidence base strongly supports a conservative, non-pharmacologic approach centered on CBT and hearing rehabilitation when appropriate, while actively avoiding ineffective and potentially harmful interventions.